Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 15, 2019 - Issue 7-8: HPV vaccination: from seroprevalence to public health policy and everything in between
Submit an article Journal homepage
1,387
Views
9
CrossRef citations to date
0
Altmetric
Short Report

Long intervals between two doses of HPV vaccines and magnitude of the immune response: a post hoc analysis of two clinical trials

Vladimir Gilcaa Division of Biological Risks, Quebec Public Health Institute, Quebec, Canada;b Division of Infectious Disease and Immunity, Laval University Research Hospital Center, Quebec, CanadaCorrespondence[email protected]
,
Chantal Sauvageaua Division of Biological Risks, Quebec Public Health Institute, Quebec, Canada;b Division of Infectious Disease and Immunity, Laval University Research Hospital Center, Quebec, Canada
,
Gitika Panickerc Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
,
Gaston De Serresa Division of Biological Risks, Quebec Public Health Institute, Quebec, Canada;b Division of Infectious Disease and Immunity, Laval University Research Hospital Center, Quebec, Canada
,
John Schillerd Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, USA
,
Manale Ouakkia Division of Biological Risks, Quebec Public Health Institute, Quebec, Canada
&
Elisabeth R. Ungerc Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
 show all
Pages 1980-1985 | Received 05 Feb 2019, Accepted 31 Mar 2019, Published online: 03 Jun 2019

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Gregory D. Zimet & Nosayaba Osazuwa-Peters. (2019) There’s Much Yet to be Done: Diverse Perspectives on HPV Vaccination. Human Vaccines & Immunotherapeutics 15:7-8, pages 1459-1464.
Read now

Articles from other publishers (8)

Élodie Bénard, Mélanie Drolet, Jean-François Laprise, Mark Jit, Kiesha Prem, Marie-Claude Boily & Marc Brisson. (2023) Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysis. The Lancet Global Health 11:1, pages e48-e58.
Crossref
Jérôme AteudjieuDavid A SackSonia Sonkeng NafackShaoming XiaoKetina Hirma Tchio-NighieHerve TchokomeniLandry Beyala Bita’aPaul Ntsekendio NyibioEtienne GuenouKedia Mayah MondungFrank Forex Kiadjieu DieumoRosanne Minone Ngome, Kelsey N. MurtMalathi RamMohammad AliAmanda K. Debes. (2022) An Age-stratified, Randomized Immunogenicity Trial of Killed Oral Cholera Vaccine with Delayed Second Dose in Cameroon. The American Journal of Tropical Medicine and Hygiene 107:5, pages 974-983.
Crossref
Mélanie Drolet, Jean-François Laprise, Dave Martin, Mark Jit, Élodie Bénard, Guillaume Gingras, Marie-Claude Boily, Michel Alary, Iacopo Baussano, Raymond Hutubessy & Marc Brisson. (2021) Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis. The Lancet Infectious Diseases 21:11, pages 1598-1610.
Crossref
Hedy Teppler, Oliver Bautista, Sheryl Flores, Jennifer McCauley & Alain Luxembourg. (2021) Design of a Phase III immunogenicity and safety study evaluating two-dose regimens of 9-valent human papillomavirus (9vHPV) vaccine with extended dosing intervals. Contemporary Clinical Trials 105, pages 106403.
Crossref
Hilary S. Whitworth, John Schiller, Lauri E. Markowitz, Mark Jit, Marc Brisson, Evan Simpson & Deborah Watson-Jones. (2021) Continued HPV vaccination in the face of unexpected challenges: A commentary on the rationale for an extended interval two-dose schedule. Vaccine 39:6, pages 871-875.
Crossref
Jacob BornsteinSurita RouxLone Kjeld PetersenLi-Min HuangSimon R. DobsonPunnee PitisuttithumJavier Diez-DomingoAndrea SchillingHany AriffinRichard TytusRichard RuppShelly SendersEli EngelDaron FerrisYae-Jean KimYoung Tae KimZafer Kurugol, Oliver Bautista, Katrina M. Nolan, Sandhya Sankaranarayanan, Alfred Saah & Alain Luxembourg. (2021) Three-Year Follow-up of 2-Dose Versus 3-Dose HPV Vaccine. Pediatrics 147:1.
Crossref
Julia ML. Brotherton. (2019) Rationalizing the HPV vaccination schedule: A long road to a worthwhile destination. Papillomavirus Research 8, pages 100190.
Crossref
Julia ML. Brotherton, Alison Budd, Christopher Rompotis, Natasha Bartlett, Michael J. Malloy, Rachael L. Andersen, Kim AR. Coulter, Peter W. Couvee, Nerida Steel, Gail H. Ward & Marion Saville. (2019) Is one dose of human papillomavirus vaccine as effective as three?: A national cohort analysis. Papillomavirus Research 8, pages 100177.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.